Current Research in Toxicology is a pioneering journal published by ELSEVIER that serves as a vital platform for disseminating cutting-edge research in the field of toxicology, spanning from biological impacts to pharmacological applications. With an ISSN of 2666-027X and an impressive Q2 ranking in key categories such as Applied Microbiology and Biotechnology, Health, Toxicology and Mutagenesis, and Toxicology, this journal underscores its commitment to high-quality research and significant contributions to the scientific community. Based in the Netherlands, Current Research in Toxicology aims to bridge the gap between academia and industry by providing rigorously peer-reviewed articles that cover a wide array of topics including novel methodologies, regulatory challenges, and emerging trends within the domain. The journal is accessible through various platforms, making it essential for researchers, professionals, and students eager to stay updated on the latest findings and advancements in toxicology. With a comprehensive focus on integrating theory with practical application, this journal is poised to influence future studies and policies in health and environmental science.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, published by Taylor & Francis Inc, stands as a key resource in the interdisciplinary field of toxicology and environmental health. Operating under the ISSN 1528-7394 and E-ISSN 1087-2620, this journal maintains a strong presence with a Q2 category ranking in Health, Toxicology and Mutagenesis and a Q3 ranking in Toxicology as of 2023. It aims to disseminate critical findings that address contemporary issues in toxicology and environmental health, emphasizing the implications of environmental agents on human health. The journal offers both subscription and open access options, making cutting-edge research accessible to a diverse readership. With coverage of key topics from 1998 to 2024, it is an essential platform for academics, professionals, and students seeking to stay at the forefront of environmental health sciences.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

The Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis is a vital publication in the fields of environmental science, toxicology, and cancer research, published by Taylor & Francis Inc. With an ISSN of 2689-6583 and E-ISSN 2689-6591, this journal provides a platform for peer-reviewed research that explores the intersection of environmental factors and health outcomes, particularly focusing on toxicological and carcinogenic impacts. Though it does not currently offer Open Access, it remains a significant contributor to academia with its current ranking in the Q4 category for Cancer Research and Q3 in Health, Toxicology and Mutagenesis. The journal has converged from 2020 to 2024 and aims to disseminate pioneering studies that inform public health policies and foster a deeper understanding of environmental toxins. Aspiring researchers, professionals, and students will find this journal to be an essential resource for the latest findings and discussions within these critical fields.

Toxics is a leading international journal published by MDPI that has been dedicated to advancing the knowledge in the fields of toxicology, environmental health, and chemical safety since its inception in 2013. With an impressive Open Access model, it ensures that all research findings are readily available to a global audience, fostering collaboration and innovation across academia and industry. The journal is esteemed for its rigorous peer-review process and holds notable rankings, including Q1 status in Chemical Health and Safety and Q2 in both Health, Toxicology and Mutagenesis and Toxicology, reflecting its impact on critical research areas. Based in Basel, Switzerland, Toxics provides a platform for researchers, professionals, and students to disseminate significant findings on the implications of toxic substances in health and the environment, aiming to improve public health outcomes and inform regulatory decisions. With its ongoing commitment to high-quality research and relevant access options, Toxics continues to be an essential resource in the domain of toxicology and environmental sciences.

REGULATORY TOXICOLOGY AND PHARMACOLOGY is a prestigious peer-reviewed journal published by Academic Press Inc. Elsevier Science, dedicated to advancing knowledge in the fields of toxicology and pharmacology. With an esteemed impact factor and a current ranking of Q2 in both Medicine and Toxicology, this journal serves as a critical resource for researchers, professionals, and students interested in the regulatory aspects of drug safety and environmental toxicology. The journal publishes original research articles, reviews, and regulatory updates that reflect the latest insights and methodologies in safety assessment and toxicological research. Established in 1970, the journal continues to play an integral role in shaping the scientific discourse around regulatory practices in pharmacology, ensuring that both academic and practical perspectives are captured. Readers can access the articles through subscription services, allowing them to stay informed of the most significant developments in the field.

Toxicological Research is a prominent academic journal dedicated to advancing the field of toxicology through rigorous exploration and innovative research. Published by the Korean Society of Toxicology, this journal serves as a vital resource for researchers, professionals, and students engaged in environmental science, pharmacology, and toxicology. With an ISSN of 1976-8257 and an E-ISSN of 2234-2753, Toxicological Research highlights significant findings and discussions in the realm of health, toxicology, and mutagenesis. Although not an open-access journal, it maintains a solid reputation as evidenced by its Q3 ranking in both health-related toxicology and general toxicology categories for 2023. The journal covers a broad spectrum of topics from fundamental research to applied toxicology and provides a unique platform for the dissemination of knowledge in a field that is increasingly relevant in today’s society. With an anticipated convergence period from 2008 to 2024, Toxicological Research continues to contribute vital insights to understanding the implications of toxic substances on health and the environment.